Searched for
INDEGENE STOCK
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Sunil Singhania picks stake in Indegene, stock up 4%Indegene shares: Abakkus was one of several institutional investors that participated in the transaction through which private equity giant...
- Carlyle group exits Indegene; sells 10.2% stake for Rs 1,447 croreGlobal investment firm Carlyle group on Wednesday exited Indegene by divesting its entire 10.2 per cent stake in digital healthcare service...
- Negative Breakout: 4 stocks cross below their 200 DMAs
- These 3 stocks closed above VWAP on March 11
- Sensex falls! But these stocks gained over 10% on BSEIn the Nifty 50 index, 29 stocks ended in the green, while 21 stocks closed in the red in today's trade.
- Porinju Veliyath highlights Ixigo, Protean and Indegene as strong long-term investment picksI do not think budget is going to make any sea change to the situation. Budget, I do not think people are having much expectation.
- Carlyle Group sells 4.3% in Indegene for ₹636 crGlobal investment firm Carlyle Group divested a 4.3% stake in Indegene for ₹636 crore via open market transactions, reducing its holding to...
- Hot stocks: Brokerages on Chola Finance, Glenmark Pharma, Indegene and Indus TowersTop brokerage firms have shared their latest stock recommendations. Investec has given a buy rating to Chola Finance and Glenmark Pharma, w...
- Hot stocks: Brokerages on DMart, Indegene, Indus Towers, Tata Motors and ONGCJPMorgan has maintained an "Overweight" rating on Tata Motors with a target price of Rs 1,250. Although JLR experienced a 1% year-over-year...
- Stock market update: Stocks that hit 52-week lows on NSE in today's tradeShriram Finance, SBI, Apollo Hospital, Hindalco and Hero MotoCorp were among the top losers on NSE in today's trade.
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeTainwala Chem, GeeCee Ventures, Ausom Enterprise, GE Power India and PNC Infratech, hit their fresh 52-week highs during the day.
- Carlyle hires 5 I-banks for $1 bn Hexaware IPOCarlyle plans to list Hexaware, aiming to raise $1 billion at a valuation of $5.5-6 billion. The move follows Carlyle's acquisition of Hexa...
- Indegene stock debuts with 46% premium over issue priceIndegene's stock debuts at Rs 659.7, a 46% premium over the issue price. The IPO, oversubscribed 70 times, raised funds for debt and capita...
- Indegene IPO shares to debut today. Here's what GMP indicatesIn the unlisted market, Indegene IPO shares are currently trading with a Grey Market Premium (GMP) of Rs 290. Given the upper price band of...
- Stocks in news: Varun Beverages, Zomato, Indegene, Tata Motors, Tata Power, Zydus LifeShares of Varun Beverages, Zomato, Jindal Steel and Tube Investments will be in focus as the companies will announce their fourth quarter r...
- Indegene IPO booked over 10x so far on Day 3. Check subscription, GMP and other detailsIndegene IPO GMP: On the final day of the initial public offer (IPO), Indegene was booked a little over 10 times so far on Wednesday, the l...
- Indegene offers value to life sciences, needs price discoveryThe Bengaluru-based company is rolling out a ₹1,842 crore initial public offering comprising a fresh issue of ₹760 crore and an offer of sa...
Load More
